Member Type: Clinical Laboratory Testing Services
Empire Genomics is a molecular diagnostics company that develops and offers a comprehensive menu of assay services for use in diagnosing and guiding precise therapeutic treatments for patients. Its mission is to improve individual patient care through the integration of innovative molecular diagnostic technologies.
Empire Genomics was created in 2006 from research that started at Roswell Park Cancer Institute in Buffalo, New York. The laboratory has a strong track record in the development of high throughput technologies to enable genome-wide analyses aimed at determining the underlying mechanisms for diseases. Having played a fundamental role in the Human Genome Project and created the foundational Bacterial Artificial Chromosomes, which served as the basis for sequencing the genome, Empire Genomics developed significant expertise in genomic research. It is from this strong experiential base that it uses its capabilities, tools and techniques to support the research, clinical and drug discovery global community.